Investing

Pre-Market Stock News (September 24, 2007)

(ADTN) ADTRAN said seasonal uptick in business for its third quarter did not materialize; shares down over 4%.
(ALOG) Analogic $0.60 EPS vs $0.52 est.
(ALTH) Allos Therapeutics announced interim results of patient response data that exceeded the pre-specified threshold for continuation of the trial; will update wider results before end of 2007.
(ARRS) Arris paying $730 million to acquire C-COR (CCBL).
(ARRY) Array Biopharma and Celgene announced a strategic global R&D collaboration.
(BHP) BHP Billiton indicated up 8% on supposedly the largest gold mine find in Australia.
(CCBL) C-COR Inc. up 27% on news of a $730 million buyout from Arris Group.
(CPHD) Cepheid entered an agreement to exclusively license HPV Portfolio developed by Quantovir AB in Europe.
(DELL) Dell is pact to sell thru GOME retail stores in China.
(GNK) Genco Shipping will sell 4 million shares in a secondary under an existing shelf offering.
(KNSY) Kensey Nash announced a $25 million share buyback.
(MESA) Mesa Air CFO put on administrative leave.
(MIPS) MIPS Technologies announced Hong Kong Applied Science & Technology Research Institute has licensed its low-power MIPS32 M4K processor core.
(MSFT) Microsoft’s HALO 3 hits shelves at midnight tonight.
(SPF) Standard Pacific announced $100 million in convertible note offering.
(VMW) VMware quiet-period ended.

Jon C. Ogg
September 24, 2007

Sponsored: Want to Retire Early? Here’s a Great First Step

Want retirement to come a few years earlier than you’d planned? Or are you ready to retire now, but want an extra set of eyes on your finances?

Now you can speak with up to 3 financial experts in your area for FREE. By simply clicking here you can begin to match with financial professionals who can help you build your plan to retire early. And the best part? The first conversation with them is free.

Click here to match with up to 3 financial pros who would be excited to help you make financial decisions.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.